Management Strategies for Acute Respiratory Distress Syndrome (ARDS)
The cornerstone of ARDS management is lung-protective ventilation with low tidal volumes (4-8 mL/kg predicted body weight) and limited plateau pressures (<30 cmH2O), supplemented by higher PEEP, prone positioning for severe cases, and adjunctive therapies including corticosteroids, neuromuscular blockade, and VV-ECMO for selected patients with refractory hypoxemia. 1
Initial Management: Ventilation Strategy
Implement lung-protective ventilation for all ARDS patients:
Apply higher PEEP without prolonged lung recruitment maneuvers in moderate to severe ARDS (conditional recommendation, low to moderate certainty) 1
Adjunctive Therapies Based on ARDS Severity
For Moderate to Severe ARDS (PaO₂/FiO₂ <200 mmHg):
Implement prone positioning for >12 hours daily (strong recommendation) 2, 6
Consider systemic corticosteroids (conditional recommendation, moderate certainty of evidence) 1
- Most effective when initiated within the first 14 days of ARDS 2
For Severe ARDS (PaO₂/FiO₂ <100 mmHg):
Consider neuromuscular blocking agents in early severe ARDS (conditional recommendation, low certainty of evidence) 1
Consider VV-ECMO for selected patients with severe ARDS who fail conventional therapy (conditional recommendation, low certainty of evidence) 1
Fluid Management and Supportive Care
Implement conservative fluid management strategy to reduce pulmonary edema while maintaining adequate organ perfusion 2, 3
Provide appropriate nutritional support 7
Implement prophylaxis for:
Monitoring and Assessment
Classify ARDS severity based on PaO₂/FiO₂ ratio: 2
- Mild: 200-300 mmHg
- Moderate: 100-200 mmHg
- Severe: <100 mmHg
Monitor for complications:
As patient improves, conduct daily spontaneous breathing trials to assess readiness for ventilator weaning 2, 7
Important Caveats and Pitfalls
Inhaled nitric oxide is ineffective in adult ARDS and should not be routinely used 8
High frequency oscillatory ventilation is not recommended for ARDS 6, 3
Delaying prone positioning in severe ARDS may miss the window of opportunity for this effective intervention 2
Initiating corticosteroids too late (>2 weeks after ARDS onset) may be harmful 2
Excessive fluid administration can worsen oxygenation and outcomes 6
Underutilization of evidence-based strategies is associated with increased mortality 2
Noninvasive ventilation has a high failure rate in moderate to severe ARDS; close monitoring for deterioration is crucial 6